| Date Filed | Type | Description |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $2.01, valued at
$20.4k
|
|
| 02/14/2022 |
5
| DRACHMAN JONATHAN G (President and CEO) has filed a Form 5 on Neoleukin Therapeutics, Inc. |
| 11/10/2021 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Bought 200,000 shares
@ $0.8595, valued at
$171.9k
|
|
| 08/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4/A
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $0 |
|
| 05/07/2021 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $22.5, valued at
$228.8k
|
|
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.25, valued at
$105k
|
|
| 06/01/2020 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $20.59, valued at
$209.3k
Granted 2,880 options to buy
@ $20.59, valued at
$59.3k
|
|
| 12/27/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| DRACHMAN JONATHAN G (See Remarks) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 1,650,000 options to buy
@ $2.8, valued at
$4.6M
|
|
| 08/12/2019 |
4
| DRACHMAN JONATHAN G (President and CEO) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 334,428 shares
@ $0
Granted 7,428 shares
@ $0 |
|
| 08/12/2019 |
3
| DRACHMAN JONATHAN G (President and CEO) has filed a Form 3 on Neoleukin Therapeutics, Inc. |
| 06/05/2019 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $11.84, valued at
$120.4k
|
|
| 06/03/2019 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.42, valued at
$59.6k
|
|
| 03/29/2019 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 4,266 options to buy
@ $14, valued at
$59.7k
|
|
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2018 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.15, valued at
$56.7k
|
|
| 03/22/2018 |
4
| DRACHMAN JONATHAN G (See Remarks) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 10,526 options to buy
@ $34.2, valued at
$360k
|
|
| 03/22/2018 |
4
| DRACHMAN JONATHAN G (CMO & EVP, R & D) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Exercised 6,468 options to buy
@ $15.46, valued at
$100k
Exercised 3,831 options to buy
@ $26.1, valued at
$100k
Exercised 7,000 options to buy
@ $10.61, valued at
$74.3k
Exercised 13,740 options to buy
@ $12, valued at
$164.9k
|
|
| 03/07/2018 |
4
| DRACHMAN JONATHAN G (CMO & EVP, R & D) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 7,200 shares
@ $52.7, valued at
$379.4k
Sold 3,257 shares
@ $53.12, valued at
$173k
Exercised 7,200 options to buy
@ $8.96, valued at
$64.5k
Exercised 3,257 options to buy
@ $8.96, valued at
$29.2k
|
|
| 01/16/2018 |
4
| DRACHMAN JONATHAN G (CMO & EVP, R & D) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Exercised 6,260 options to buy
@ $12, valued at
$75.1k
Exercised 13,156 options to buy
@ $10.61, valued at
$139.6k
|
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|